MedPath

ALLIANCE PHARMACEUTICALS

🇳🇵Nepal
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:2
Completed:1

Trial Phases

2 Phases

Phase 1:2
Phase 4:1

Drug Approvals

23

EMC:23

Drug Approvals

Occlusal

Approval Date
Jul 7, 2025
EMC

Paludrine 100 mg Tablets

Approval Date
Jul 7, 2025
EMC

Buccastem M Buccal Tablets

Approval Date
Jul 7, 2025
EMC

Aspirin 300

Approval Date
Jul 7, 2025
EMC

Anbesol Liquid

Approval Date
Jul 7, 2025
EMC

Anbesol Adult Strength Gel

Approval Date
Jul 7, 2025
EMC

Avloclor Tablets

Approval Date
Jul 7, 2025
EMC

Prochlorperazine 3 mg Buccal Tablets

Approval Date
Jul 7, 2025
EMC

Periostat 20mg film-coated tablets

Approval Date
Jul 7, 2025
EMC

Isocarboxazid Tablets 10mg

Approval Date
Jul 7, 2025
EMC
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 4
1 (33.3%)

A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation

Phase 4
Completed
Conditions
Pediculosis Capitis
Lice Infestations
Head Lice
Interventions
Other: Vamousse Spray 'n' Go
Drug: Nix Creme Rinse Lice Treatment
First Posted Date
2022-10-04
Last Posted Date
2025-02-24
Lead Sponsor
Alliance Pharmaceuticals
Target Recruit Count
58
Registration Number
NCT05565820
Locations
🇺🇸

South Florida Family Health and Research Centers, LLC., Miami, Florida, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.